| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.6 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |